Hi! Simply click below and type your query.
Our experts will reply you very soon.
Kandivali West, Mumbai, Maharashtra
Pharmacopoeia | IP/IH |
Molar Mass | 464.825 g/mol |
CAS ID | 284461-73-0 |
Formula | C21H16ClF3N4O3 |
Click to view more |
Preferred Buyer From
Location | All Countries Except India |
Product Details
Sorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma.